Modulation of inducible nitric oxide synthase (iNOS) expression and cardiovascular responses during static exercise following iNOS antagonism within the ventrolateral medulla

[1]  J. Duarte,et al.  Modulation of nitric oxide by flavonoids. , 2014, Food & function.

[2]  D. Della-Morte,et al.  Drugs targeting nitric oxide synthase for migraine treatment , 2014, Expert opinion on investigational drugs.

[3]  R. Rapoport.  Acute nitric oxide synthase inhibition and endothelin-1-dependent arterial pressure elevation , 2014, Front. Pharmacol..

[4]  M. Hezel,et al.  Cross-talk Between Nitrate-Nitrite-NO and NO Synthase Pathways in Control of Vascular NO Homeostasis. , 2014, Antioxidants & redox signaling.

[5]  J. Tanus-Santos,et al.  Inducible nitric oxide synthase as a possible target in hypertension. , 2014, Current drug targets.

[6]  H. H. ChanSamuel,et al.  Brain Stem NOS and ROS in Neural Mechanisms of Hypertension , 2014 .

[7]  C. Vecchione,et al.  Adrenoreceptors and nitric oxide in the cardiovascular system , 2013, Front. Physiol..

[8]  Zhihui Qin,et al.  Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy. , 2013, Future medicinal chemistry.

[9]  T. Maher,et al.  Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke. , 2013, Canadian journal of physiology and pharmacology.

[10]  Nirmal Singh,et al.  Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats , 2013, Pharmacology Biochemistry and Behavior.

[11]  Y. Tain,et al.  Aminoguanidine attenuates hypertension, whereas 7-nitroindazole exacerbates kidney damage in spontaneously hypertensive rats: the role of nitric oxide. , 2013, European journal of pharmacology.

[12]  P. Evora,et al.  Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. , 2012, Current drug targets.

[13]  C. Pẽna,et al.  Angiotensin-(1–7) upregulates central nitric oxide synthase in spontaneously hypertensive rats , 2012, Brain Research.

[14]  T. Maher,et al.  Transient middle cerebral artery occlusion and reperfusion alters inducible NOS expression within the ventrolateral medulla and modulates cardiovascular function during static exercise. , 2011, Canadian journal of physiology and pharmacology.

[15]  C. Price,et al.  Regulation of inducible nitric oxide synthase expression in bovine ovarian granulosa cells , 2011, Molecular and Cellular Endocrinology.

[16]  M. Dolnikoff,et al.  Upregulation of AT1R and iNOS in the rostral ventrolateral medulla (RVLM) is essential for the sympathetic hyperactivity and hypertension in the 2K-1C Wistar rat model. , 2010, American journal of hypertension.

[17]  A. Tedesco,et al.  Angiotensin II type-2 (AT2) receptor antagonism alters cardiovascular responses to static exercise and simultaneously changes glutamate/GABA levels within the ventrolateral medulla , 2009, Neuroscience Research.

[18]  M. Toborek,et al.  Nicotine attenuates iNOS expression and contributes to neuroprotection in a compressive model of spinal cord injury , 2009, Journal of neuroscience research.

[19]  K. Sunagawa,et al.  Role of Inducible Nitric Oxide Synthase in Rostral Ventrolateral Medulla in Blood Pressure Regulation in Spontaneously Hypertensive Rats , 2009, Clinical and experimental hypertension.

[20]  N. Feng,et al.  Inducible nitric oxide synthase expressions in different lung injury models and the protective effect of aminoguanidine. , 2008, Transplantation proceedings.

[21]  Shruti V. Kabadi,et al.  Neuronal Nitric Oxide Synthase (nNOS) blockade within the ventrolateral medulla differentially modulates cardiovascular responses and nNOS expression during static skeletal muscle contraction , 2007, Brain Research.

[22]  Ming Yan,et al.  The role of iNOS-derived NO in the antihypertrophic actions of B-type natriuretic peptide in neonatal rat cardiomyocytes , 2007, Molecular and Cellular Biochemistry.

[23]  M. Martins-Pinge,et al.  Differential influence of iNOS and nNOS inhibitors on rostral ventrolateral medullary mediated cardiovascular control in conscious rats , 2007, Autonomic Neuroscience.

[24]  I. Singh,et al.  Pharmacological strategies for the regulation of inducible nitric oxide synthase: Neurodegenerative versus neuroprotective mechanisms , 2006, Neurochemistry International.

[25]  Shruti V. Kabadi,et al.  Cardiovascular responses and neurotransmitter changes during static muscle contraction following blockade of inducible nitric oxide synthase (iNOS) within the ventrolateral medulla , 2006, Brain Research.

[26]  J. Balligand,et al.  Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. , 2005, Pharmacology & therapeutics.

[27]  S. Nauli,et al.  Molecular changes in nNOS protein expression within the ventrolateral medulla following transient focal ischemia affect cardiovascular functions , 2005, Brain Research.

[28]  P. Bath,et al.  Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. , 2005, Free radical biology & medicine.

[29]  T. Maher,et al.  Neurochemistry within ventrolateral medulla and cardiovascular effects during static exercise following eNOS antagonism , 2005, Neuroscience Research.

[30]  S. Moochhala,et al.  The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats. , 2005, The Journal of surgical research.

[31]  S. Gross,et al.  The Mechanism of Potent GTP Cyclohydrolase I Inhibition by 2,4-Diamino-6-hydroxypyrimidine , 2004, Journal of Biological Chemistry.

[32]  O. Hurtado,et al.  Role of nitric oxide after brain ischaemia. , 2004, Cell calcium.

[33]  Mushfiquddin Khan,et al.  A Novel Role of Lactosylceramide in the Regulation of Lipopolysaccharide/Interferon-γ-Mediated Inducible Nitric Oxide Synthase Gene Expression: Implications for Neuroinflammatory Diseases , 2004, The Journal of Neuroscience.

[34]  S. Nauli,et al.  Cardiovascular responses and neurotransmitter changes following blockade of nNOS within the ventrolateral medulla during static muscle contraction , 2003, Brain Research.

[35]  Jianhua Li.  Nitric oxide synthase (NOS) coexists with activated neurons by skeletal muscle contraction in the brainstem of cats. , 2002, Life sciences.

[36]  S. Nauli,et al.  Cardiovascular responses and neurotransmission in the ventrolateral medulla during skeletal muscle contraction following transient middle cerebral artery occlusion and reperfusion , 2002, Brain Research.

[37]  S. Nauli,et al.  Simultaneous glutamate and γ-aminobutyric acid release within ventrolateral medulla during skeletal muscle contraction in intact and barodenervated rats , 2001, Brain Research.

[38]  Y. Hirooka,et al.  Role of Nitric Oxide in Central Sympathetic Outflow , 2001, Experimental biology and medicine.

[39]  A. Takeshita,et al.  Overexpression of eNOS in the RVLM Causes Hypotension and Bradycardia Via GABA Release , 2001, Hypertension.

[40]  J. Chan,et al.  Differential cardiovascular responses to blockade of nNOS or iNOS in rostral ventrolateral medulla of the rat , 2001, British journal of pharmacology.

[41]  T. Yoshimoto,et al.  Distribution of c-fos mRNA in the brain following intracerebroventricular injection of nitric oxide (NO)-releasing compounds: possible role of NO in central cardiovascular regulation. , 2000, Journal of neuroendocrinology.

[42]  Y. Hara,et al.  Glutamate neurotransmission and nitric oxide interaction within the ventrolateral medulla during cardiovascular responses to muscle contraction , 2000, Brain Research.

[43]  O. Hurtado,et al.  Implication of Glutamate in the Expression of Inducible Nitric Oxide Synthase After Oxygen and Glucose Deprivation in Rat Forebrain Slices , 2000, Journal of neurochemistry.

[44]  B. Freda,et al.  Cardiovascular responses to muscle contraction following microdialysis of nitric oxide precursor into ventrolateral medulla , 1999, Brain Research.

[45]  H. Demura,et al.  Distinct distribution and time-course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus following lipopolysaccharide injection , 1999, Brain Research.

[46]  A. Ally.  Ventrolateral medullary control of cardiovascular activity during muscle contraction , 1998, Neuroscience & Biobehavioral Reviews.

[47]  A. Namboodiri,et al.  Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. , 1997, The Journal of clinical investigation.

[48]  H. Seller,et al.  Species differences in the distribution of nitric oxide synthase in brain stem regions that regulate sympathetic activity , 1997, Brain Research.

[49]  J. Büttner-Ennever.  The Rat Brain in Stereotaxic Coordinates, 3rd edn. By George Paxinos and Charles Watson. (Pp. xxxiii+80; illustrated; £$69.95 paperback; ISBN 0 12 547623; comes with CD‐ROM.) San Diego: Academic Press. 1996. , 1997 .

[50]  D. Mokler,et al.  Central 5-HT1A modulation of cardiovascular responses to tibial nerve stimulation-evoked muscle contraction. , 1997, The American journal of physiology.

[51]  H. Seller,et al.  Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. , 1995, The American journal of physiology.

[52]  A. Aviv,et al.  Duality of plasmin effect on cytosolic free calcium in human platelets. , 1995, The American journal of physiology.

[53]  D. Reis,et al.  Synthesis of nitric oxide in CNS glial cells , 1993, Trends in Neurosciences.

[54]  Larry W. Swanson,et al.  Brain Maps: Structure of the Rat Brain , 1992 .

[55]  S. Snyder,et al.  Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Snyder,et al.  Localization of nitric oxide synthase indicating a neural role for nitric oxide , 1990, Nature.

[57]  Ching-Feng Cheng,et al.  The prostaglandin agonist beraprost aggravates doxorubicin-mediated apoptosis by increasing iNOS expression in cardiomyocytes. , 2015, Current vascular pharmacology.

[58]  W. Habscheid,et al.  [Stroke -- therapy]. , 2004, Deutsche medizinische Wochenschrift.

[59]  M. Fisher.  Stroke Therapy (2nd ed.) , 2001 .

[60]  J. Chan,et al.  Differential roles of iNOS and nNOS at rostral ventrolateral medulla during experimental endotoxemia in the rat. , 2001, Shock.

[61]  U. Förstermann,et al.  Expression and expressional control of nitric oxide synthases in various cell types. , 1995, Advances in pharmacology.

[62]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .